Last reviewed · How we verify

SII-YFV

Serum Institute of India Pvt. Ltd. · Phase 3 active Biologic

SII-YFV is a vaccine Biologic drug developed by Serum Institute of India Pvt. Ltd.. It is currently in Phase 3 development for Prevention of yellow fever in individuals 9 months of age and older.

SII-YFV is a vaccine that stimulates an immune response against the yellow fever virus.

SII-YFV is a vaccine that stimulates an immune response against the yellow fever virus. Used for Prevention of yellow fever in individuals 9 months of age and older.

At a glance

Generic nameSII-YFV
SponsorSerum Institute of India Pvt. Ltd.
Drug classvaccine
ModalityBiologic
Therapeutic areaInfectious Diseases
PhasePhase 3

Mechanism of action

The vaccine contains live, attenuated yellow fever virus which, when administered, prompts the body's immune system to produce antibodies against the virus, thereby providing protection against future infection.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about SII-YFV

What is SII-YFV?

SII-YFV is a vaccine drug developed by Serum Institute of India Pvt. Ltd., indicated for Prevention of yellow fever in individuals 9 months of age and older.

How does SII-YFV work?

SII-YFV is a vaccine that stimulates an immune response against the yellow fever virus.

What is SII-YFV used for?

SII-YFV is indicated for Prevention of yellow fever in individuals 9 months of age and older.

Who makes SII-YFV?

SII-YFV is developed by Serum Institute of India Pvt. Ltd. (see full Serum Institute of India Pvt. Ltd. pipeline at /company/serum-institute-of-india-pvt-ltd).

What drug class is SII-YFV in?

SII-YFV belongs to the vaccine class. See all vaccine drugs at /class/vaccine.

What development phase is SII-YFV in?

SII-YFV is in Phase 3.

What are the side effects of SII-YFV?

Common side effects of SII-YFV include Injection site reactions (pain, redness, swelling), Fever.

Related